Targeting cancer cells with mutated KRAS with krasin, a novel synthetic cycloheptapeptide

被引：0
|
作者：
Sheikhnejad, R. [1 ]
Tahoori, F. [1 ]
Shokri, B. [1 ]
机构：
[1] Oshida Novel Pharmatech, Incubat Ctr Pharmaceut Technol, Tehran, Iran
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 61卷
关键词：
D O I：
10.1016/S0959-8049(16)61733-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
895
引用
收藏
页码：S208 / S208
页数：1
相关论文
共 50 条
  • [41] Targeting the untargetable KRAS in cancer therapy
    Liu, Pingyu
    Wang, Yijun
    Li, Xin
    ACTA PHARMACEUTICA SINICA B, 2019, 9 (05) : 871 - 879
  • [42] Targeting Oncogenic KRAS in Pancreatic Cancer
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (04) : 569 - 569
  • [43] Intrinsic resistance mechanisms to mutant KRAS specific inhibitor in KRAS mutated colorectal cancer
    Maruyama, Kohei
    Suzuki, Mai
    Ohhara, Tomoko
    Nagayama, Satoshi
    Fujita, Naoya
    Katayama, Ryohei
    CANCER SCIENCE, 2023, 114 : 1210 - 1210
  • [44] Acetylation is increased in KRAS mutated colorectal cancer cells that are resistant to anti-EGFR therapies
    Roda, D.
    Zaragoza, R.
    Fernandez, E.
    Torres, L.
    Garcia-Trevijano, E. R.
    Cervantes, A.
    FEBS JOURNAL, 2012, 279 : 311 - 312
  • [45] Advanced therapies on BRAF-mutated and KRAS-mutated metastatic colorectal cancer
    LI Zi-nan
    YU Li-feng
    WANG Jia-qi
    NIU Yan-xin
    WANG Xin-yu
    ZHAO Lin
    中国药理学与毒理学杂志, 2019, (10) : 883 - 883
  • [46] Acquired Resistance to Anti EGFR Therapy in Colorectal Cancer and Paracrine Protection by KRAS Mutated Cells
    Hobor, S.
    Misale, S.
    Crowley, E.
    Scala, E.
    Zanon, C.
    Di Nicolantonio, F.
    Bardelli, A.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 51 - 51
  • [47] Intrinsic resistance mechanisms to mutant KRAS specific inhibitor in KRAS mutated colorectal cancer
    Maruyama, Kohei
    Suzuki, Mai
    Ohhara, Tomoko
    Nagayama, Satoshi
    Fujita, Naoya
    Katayama, Ryohei
    CANCER SCIENCE, 2023, 114 : 783 - 783
  • [48] Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that interfere the binding between KRAS and GTP/GDP
    Xia, Yannan
    Zhang, Shujie
    Luo, Hongyi
    Wang, Yumeng
    Jiang, Yuanyuan
    Jiang, Jingwei
    Yuan, Shengtao
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 961
  • [49] Identification of T -cell receptors targeting KRAS-mutated human tumors
    Wang, Qiong J.
    Yu, Zhiya
    Hanada, Kenichi
    Restifo, Nicholas P.
    Yang, James C.
    CANCER RESEARCH, 2016, 76
  • [50] Development of a mouse model of KRAS mutated colorectal cancer tumorigenesis
    Maitra, Radhashree
    Venkatesh, Madhu Kumar
    Augustine, Titto Alby
    Chandy, Carol
    Liu, Qiang
    Goel, Sanjay
    CANCER RESEARCH, 2017, 77
12345